NCT02029443 2026-02-06ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (BTK) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia, Richter's Syndrome or Prolymphocytic LeukemiaAcerta Pharma BVPhase 1/2 Active not recruiting306 enrolled 26 charts
NCT00587457 2017-07-06A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic LeukemiaMedImmune LLCPhase 1 Terminated11 enrolled 14 charts
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts